<unk>  is a bisphosphonate that is FDA approved for the treatment of hypercalcemia of malignancy, Paget's disease, osteolytic bone metastases of breast cancer and osteolytic lesions of multiple myeloma.   Common adverse reactions include hypertension, injection site reactiion, hypocalcemia, hypokalemia, hypomagnesemia, hypophosphatemia, loss of appetite, nausea, vomiting, anemia, urinary tract infectious disease, cough, dyspnea, fatigue, and malaise.
Pamidronic acid
Etidronic acid
Zoledronic acid
Etidronate
Risedronate
Tiludronate
Alendronate
Ibandronate 